Recruiting
Phase 1

Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer

Sponsor:

City of Hope Medical Center

Code:

NCT05340673

Conditions

Breast Ductal Carcinoma In Situ

Invasive Breast Carcinoma

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Agent Affecting Integumentary System

Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment

Quality-of-Life Assessment

Questionnaire Administration

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-29. This information was provided to ClinicalTrials.gov by City of Hope Medical Center on 2024-06-18.